approval
saveRELGAABI (GABAPENTIN) — FDA approval
February 17, 2026updated 5mo ago
community read0 votes
Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalGABAPENTIN — FDA approvalFeb 17, 2026
- approvalATORVASTATIN CALCIUM — FDA approvalJan 22, 2026
- approvalDESOXIMETASONE — FDA approvalMar 16, 2026
- approvalDESOXIMETASONE — FDA approvalMar 16, 2026
- approvalOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMar 31, 2026
- approvalDILTIAZEM HYDROCHLORIDE — FDA approvalApr 10, 2026
comments(0)
5-min edit window · permanent after that